Age-dependent effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)
- 1 June 1985
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 24 (6), 581-583
- https://doi.org/10.1016/0028-3908(85)90068-1
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- IX. Neurochemical and functional consequences following 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) and methamphetamineLife Sciences, 1985
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Pargyline Prevents MPTP-Induced Parkinsonism in PrimatesScience, 1984
- Tolerance following the repeated administration of high doses of phencyclidine: No relation to central catecholamine depletionDrug and Alcohol Dependence, 1984
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidaseBiochemical and Biophysical Research Communications, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Differential Changes in Monoamine Oxidase A and B Activity in the Aging Rat BrainJournal of Neurochemistry, 1980
- The development of monoamine oxidase in rat liver and brainFEBS Letters, 1976